Effect of short-term exercise training on angiogenic growth factor gene responses in rats

被引:59
作者
Gavin, TP [1 ]
Wagner, PD [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
vascular endothelial growth factor; transforming growth factor-beta(1); basic fibroblast growth factor; Northern analysis; citrate synthase activity;
D O I
10.1152/jappl.2001.90.4.1219
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We investigated whether 1) 5 days of exercise training would reduce the acute exercise-induced increase in skeletal muscle growth factor gene expression; and 2) reductions in the increase in growth factor gene expression in response to short-term exercise training would be coincident with increases in skeletal muscle oxidative potential. Female Wistar rats were used. Six groups (rest; exercise for 1-5 consecutive days) were used to measure the growth factor response through the early phases of an exercise training program. Vascular endothelial growth factor (VEGF), transforming growth factor-beta (1), (TGF-beta (1)), and basic fibroblast growth factor (bFGF) mRNA were analyzed from the left gastrocnemius by quantitative Northern blot. Citrate synthase activity was analyzed from the right gastrocnemius. VEGF and TGF-beta, mRNA increased after each of 5 days of exercise training, whereas exercise on any day did not increase bFGF mRNA. On day 1, the VEGF mRNA response was significantly greater than on days 2-5. However, the reduced increase in VEGF mRNA observed on days 2-5 was not coincident with increases in citrate synthase activity. These findings suggest that, in skeletal muscle, 1) VEGF and TGF-beta, mRNA are increased through 5 days of exercise training and 2) the reduced exercise-induced increase in VEGF mRNA responses on days 2-5 does not result from increases in oxidative potential.
引用
收藏
页码:1219 / 1226
页数:8
相关论文
共 50 条
  • [21] The short-term effects of intravitreal injection of bevacizumab on the plasma levels of vascular endothelial growth factor, insulin-like growth factor-1, and growth parameters in infants with retinopathy of prematurity
    Sedaghat, Ahad
    Abdolalizadeh, Parya
    Parvaresh, Mohammad Mehdi
    Ghorbanizadeh, Sajad
    Mohagheghi, Parisa
    Aghdaml, Kaveh Abri
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2020, 32 (02): : 159 - 163
  • [22] Investigation of+405 and-460 polymorphisms of vascular endothelial growth factor in psoriasis and short-term responsiveness to efalizumab therapy
    Stefanaki, I.
    Dimisianos, G.
    Antoniou, C.
    Katsambas, A.
    Stratigos, A.
    DERMATOLOGY, 2008, 217 (03) : 201 - 202
  • [23] Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats
    Nakano, Ayuki
    Nakahara, Tsutomu
    Mori, Asami
    Ushikubo, Hiroko
    Sakamoto, Kenji
    Ishii, Kunio
    EXPERIMENTAL EYE RESEARCH, 2016, 143 : 120 - 131
  • [24] Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: Short-term study
    FrancisTurner, L
    Valouskova, V
    NEUROSCIENCE LETTERS, 1996, 202 (03) : 193 - 196
  • [25] Aerobic Training Improves Angiogenic Potential Independently of Vascular Endothelial Growth Factor Modifications in Postmenopausal Women
    Izzicupo, Pascal
    D'Amico, Maria A.
    Di Blasio, Andrea
    Napolitano, Giorgio
    Nakamura, Fabio Y.
    Di Baldassarre, Angela
    Ghinassi, Barbara
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [26] Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease
    Kim, HJ
    Jang, SY
    Park, JI
    Byun, J
    Kim, DI
    Do, YS
    Kim, JM
    Kim, S
    Kim, BM
    Kim, WB
    Kim, DK
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2004, 36 (04) : 336 - 344
  • [27] Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension
    Zacharieva, S
    Atanassova, I
    Natchev, E
    Orbetzova, M
    Tzingilev, D
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (03): : 153 - 156
  • [28] Angiogenic gene therapy with vascular endothelial growth factor — Hope or hype?Angiogenetische Gentherapie mit „Vascular Endothelial Growth Factor“ — Hoffnung oder Illusion?
    J. Dulak
    Alicja Jozkowicz
    European Surgery, 2002, 34 (2) : 101 - 104
  • [29] Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease
    Hyun-Joong Kim
    Shin Yi Jang
    Joong-Il Park
    Jonghoe Byun
    Dong-Ik Kim
    Young-Soo Do
    Jong-Mook Kim
    Sunyoung Kim
    Byong-Moon Kim
    Won-Bae Kim
    Duk-Kyung Kim
    Experimental & Molecular Medicine, 2004, 36 : 336 - 344
  • [30] THE EFFECT OF COMBINED EXERCISE TRAINING ON CAROTID ARTERY STRUCTURE AND FUNCTION, AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN OBESE OLDER WOMEN
    Park, Jinkee
    Nakamura, Yoshio
    Kwon, Yoochan
    Park, Hyuntae
    Kim, Eunhee
    Park, Sangkab
    JAPANESE JOURNAL OF PHYSICAL FITNESS AND SPORTS MEDICINE, 2010, 59 (05) : 495 - 503